Tag results:
glioblastoma
Extracellular Matrix News
Metabolic and Transcriptomic Profiles of Glioblastoma Invasion Revealed by Comparisons between Patients and Corresponding Orthotopic Xenografts in Mice
[Acta Neuropathologica] Researchers reported biological features of invasive growth accompanying tumor progression and invasion based on associated metabolic and transcriptomic changes observed in patient derived orthotopic xenografts in the mouse and the corresponding patients’ tumors.
Neural Cell News
IL-10 in Glioma
[British Journal of Cancer] Researchers discuss the immunostimulatory and immunosuppressive roles of interleukin-10 (IL-10) in the glioblastoma tumour microenvironment while considering IL-10-targeted treatment strategies.
Mesenchymal Cell News
Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses
[Stem Cell Reviews and Reports] Scientists summarize findings to advocate the reactivation of tumor suppressors p53 and PTEN in glioblastoma treatment and use MSCs as a “Trojan horse” to carry oncolytic viral cargo to disseminated tumor beds.
Neural Cell News
ERBB3 Overexpression Due to miR-205 Inactivation Confers Sensitivity to FGF, Metabolic Activation, and Liability to ERBB3 Targeting in Glioblastoma
[Cell Reports] Researchers identified a human glioblastoma subset characterized by ERBB3 overexpression and nuclear accumulation.
Cancer Stem Cell News
Autophagy Inhibition Reinforces Stemness Together with Exit from Dormancy of Polydisperse Glioblastoma Stem Cells
[Aging-Us] The authors silenced two autophagy related genes -either Beclin1 or ATG5- by shRNA and they explored the ensuing consequences on CSCs markers’ expression and functionalities.
Cancer Stem Cell News
Elevated Cellular PpIX Potentiates Sonodynamic Therapy in a Mouse Glioma Stem Cell-Bearing Glioma Model by Downregulating the Akt/NF-κB/MDR1 Pathway
[Scientific Reports] In high invasive progeny cells from mouse glioma stem cells (GSCs) and a GSC-bearing mouse glioma model, researchers assessed the anti-tumor effects of sonodynamic therapy with a COX-2 inhibitor, celecoxib.